AAPL351.63+9.26 (+2.70%) ▲|ABBV292.69+1.38 (+0.47%) ▲|ABT110.48+0.55 (+0.50%) ▲|ACN255.33-5.17 (-1.98%) ▼|ADBE237.28-2.03 (-0.85%) ▼|AMAT374.09+41.38 (+12.44%) ▲|AMD512.92+63.88 (+14.23%) ▲|AMGN464.40+3.98 (+0.86%) ▲|AMT189.45+0.66 (+0.35%) ▲|AMZN268.80+9.50 (+3.66%) ▲|AVGO322.24+28.55 (+9.72%) ▲|AXP325.49+4.50 (+1.40%) ▲|BA173.77+0.37 (+0.21%) ▲|BAC50.87+1.45 (+2.92%) ▲|BKNG163.56+2.90 (+1.80%) ▲|BLK1,223.18+44.31 (+3.76%) ▲|BMY62.44+0.30 (+0.48%) ▲|BNY151.65+3.93 (+2.66%) ▲|BRK-B577.33+6.44 (+1.13%) ▲|C122.25+3.20 (+2.69%) ▲|CAT597.80+39.17 (+7.01%) ▲|CL97.89+1.33 (+1.38%) ▲|CMCSA24.46+0.07 (+0.27%) ▲|COF199.58-2.30 (-1.14%) ▼|COP134.33-1.94 (-1.43%) ▼|COST1,061.71+8.15 (+0.77%) ▲|CRM215.33+1.68 (+0.78%) ▲|CSCO99.26+5.41 (+5.76%) ▲|CVS84.49+0.64 (+0.76%) ▲|CVX210.18-2.43 (-1.14%) ▼|DE695.14+23.49 (+3.50%) ▲|DHR236.17+5.92 (+2.57%) ▲|DIS119.18+2.43 (+2.08%) ▲|DUK128.99+1.21 (+0.95%) ▲|EMR171.54+9.19 (+5.66%) ▲|FDX320.39+12.25 (+3.97%) ▲|GD363.10+9.04 (+2.55%) ▲|GE337.15+13.91 (+4.30%) ▲|GEV836.34+62.23 (+8.04%) ▲|GILD169.74+2.85 (+1.71%) ▲|GM89.90+3.74 (+4.34%) ▲|GOOG287.61+3.68 (+1.30%) ▲|GOOGL289.53+4.75 (+1.67%) ▲|GS909.32+43.50 (+5.02%) ▲|HD356.01+12.54 (+3.65%) ▲|HON229.68+9.63 (+4.38%) ▲|IBM248.63+3.63 (+1.48%) ▲|INTC59.41+3.13 (+5.56%) ▲|INTU337.94-3.56 (-1.04%) ▼|ISRG461.52+8.72 (+1.93%) ▲|JNJ282.27+6.05 (+2.19%) ▲|JPM342.73+8.24 (+2.46%) ▲|KO95.78+0.11 (+0.11%) ▲|LIN522.92+7.67 (+1.49%) ▲|LLY1,418.19+64.19 (+4.74%) ▲|LMT588.14+21.06 (+3.71%) ▲|LOW233.64+9.09 (+4.05%) ▲|LRCX221.58+21.14 (+10.55%) ▲|MA658.62+5.92 (+0.91%) ▲|MCD282.33+5.81 (+2.10%) ▲|MDLZ66.49+0.47 (+0.70%) ▲|MDT103.29+1.49 (+1.46%) ▲|META646.67+36.52 (+5.99%) ▲|MMM190.02+4.87 (+2.63%) ▲|MO75.76-0.36 (-0.47%) ▼|MRK148.12+1.39 (+0.95%) ▲|MS187.68+6.24 (+3.44%) ▲|MSFT547.77+17.16 (+3.23%) ▲|MU739.61+49.61 (+7.19%) ▲|NEE87.19+0.24 (+0.27%) ▲|NFLX63.74+0.33 (+0.51%) ▲|NKE40.07+1.48 (+3.82%) ▲|NOW103.52+1.55 (+1.52%) ▲|NVDA178.11-8.54 (-4.57%) ▼|ORCL119.85+3.75 (+3.23%) ▲|PEP142.31+0.97 (+0.69%) ▲|PFE29.42+0.03 (+0.09%) ▲|PG168.55+3.15 (+1.90%) ▲|PLTR170.42+10.04 (+6.26%) ▲|PM193.24-4.64 (-2.34%) ▼|QCOM172.34+6.93 (+4.19%) ▲|RTX196.82+7.29 (+3.85%) ▲|SBUX110.06+4.65 (+4.41%) ▲|SCHW93.23+1.74 (+1.90%) ▲|SO93.80+1.46 (+1.58%) ▲|SPG233.06+4.64 (+2.03%) ▲|T21.65+0.02 (+0.07%) ▲|TMO720.46+25.70 (+3.70%) ▲|TMUS168.60+6.59 (+4.07%) ▲|TSLA381.00+22.78 (+6.36%) ▲|TXN295.80+18.44 (+6.65%) ▲|UBER71.06+2.47 (+3.60%) ▲|UNH396.99+2.84 (+0.72%) ▲|UNP296.64+6.48 (+2.23%) ▲|UPS111.69+3.39 (+3.13%) ▲|USB61.15+1.70 (+2.85%) ▲|V422.36-0.30 (-0.07%) ▼|VZ45.95+0.26 (+0.56%) ▲|WFC85.80+1.86 (+2.22%) ▲|WMT125.63+0.11 (+0.09%) ▲|XOM164.47-1.41 (-0.85%) ▼|AAPL351.63+9.26 (+2.70%) ▲|ABBV292.69+1.38 (+0.47%) ▲|ABT110.48+0.55 (+0.50%) ▲|ACN255.33-5.17 (-1.98%) ▼|ADBE237.28-2.03 (-0.85%) ▼|AMAT374.09+41.38 (+12.44%) ▲|AMD512.92+63.88 (+14.23%) ▲|AMGN464.40+3.98 (+0.86%) ▲|AMT189.45+0.66 (+0.35%) ▲|AMZN268.80+9.50 (+3.66%) ▲|AVGO322.24+28.55 (+9.72%) ▲|AXP325.49+4.50 (+1.40%) ▲|BA173.77+0.37 (+0.21%) ▲|BAC50.87+1.45 (+2.92%) ▲|BKNG163.56+2.90 (+1.80%) ▲|BLK1,223.18+44.31 (+3.76%) ▲|BMY62.44+0.30 (+0.48%) ▲|BNY151.65+3.93 (+2.66%) ▲|BRK-B577.33+6.44 (+1.13%) ▲|C122.25+3.20 (+2.69%) ▲|CAT597.80+39.17 (+7.01%) ▲|CL97.89+1.33 (+1.38%) ▲|CMCSA24.46+0.07 (+0.27%) ▲|COF199.58-2.30 (-1.14%) ▼|COP134.33-1.94 (-1.43%) ▼|COST1,061.71+8.15 (+0.77%) ▲|CRM215.33+1.68 (+0.78%) ▲|CSCO99.26+5.41 (+5.76%) ▲|CVS84.49+0.64 (+0.76%) ▲|CVX210.18-2.43 (-1.14%) ▼|DE695.14+23.49 (+3.50%) ▲|DHR236.17+5.92 (+2.57%) ▲|DIS119.18+2.43 (+2.08%) ▲|DUK128.99+1.21 (+0.95%) ▲|EMR171.54+9.19 (+5.66%) ▲|FDX320.39+12.25 (+3.97%) ▲|GD363.10+9.04 (+2.55%) ▲|GE337.15+13.91 (+4.30%) ▲|GEV836.34+62.23 (+8.04%) ▲|GILD169.74+2.85 (+1.71%) ▲|GM89.90+3.74 (+4.34%) ▲|GOOG287.61+3.68 (+1.30%) ▲|GOOGL289.53+4.75 (+1.67%) ▲|GS909.32+43.50 (+5.02%) ▲|HD356.01+12.54 (+3.65%) ▲|HON229.68+9.63 (+4.38%) ▲|IBM248.63+3.63 (+1.48%) ▲|INTC59.41+3.13 (+5.56%) ▲|INTU337.94-3.56 (-1.04%) ▼|ISRG461.52+8.72 (+1.93%) ▲|JNJ282.27+6.05 (+2.19%) ▲|JPM342.73+8.24 (+2.46%) ▲|KO95.78+0.11 (+0.11%) ▲|LIN522.92+7.67 (+1.49%) ▲|LLY1,418.19+64.19 (+4.74%) ▲|LMT588.14+21.06 (+3.71%) ▲|LOW233.64+9.09 (+4.05%) ▲|LRCX221.58+21.14 (+10.55%) ▲|MA658.62+5.92 (+0.91%) ▲|MCD282.33+5.81 (+2.10%) ▲|MDLZ66.49+0.47 (+0.70%) ▲|MDT103.29+1.49 (+1.46%) ▲|META646.67+36.52 (+5.99%) ▲|MMM190.02+4.87 (+2.63%) ▲|MO75.76-0.36 (-0.47%) ▼|MRK148.12+1.39 (+0.95%) ▲|MS187.68+6.24 (+3.44%) ▲|MSFT547.77+17.16 (+3.23%) ▲|MU739.61+49.61 (+7.19%) ▲|NEE87.19+0.24 (+0.27%) ▲|NFLX63.74+0.33 (+0.51%) ▲|NKE40.07+1.48 (+3.82%) ▲|NOW103.52+1.55 (+1.52%) ▲|NVDA178.11-8.54 (-4.57%) ▼|ORCL119.85+3.75 (+3.23%) ▲|PEP142.31+0.97 (+0.69%) ▲|PFE29.42+0.03 (+0.09%) ▲|PG168.55+3.15 (+1.90%) ▲|PLTR170.42+10.04 (+6.26%) ▲|PM193.24-4.64 (-2.34%) ▼|QCOM172.34+6.93 (+4.19%) ▲|RTX196.82+7.29 (+3.85%) ▲|SBUX110.06+4.65 (+4.41%) ▲|SCHW93.23+1.74 (+1.90%) ▲|SO93.80+1.46 (+1.58%) ▲|SPG233.06+4.64 (+2.03%) ▲|T21.65+0.02 (+0.07%) ▲|TMO720.46+25.70 (+3.70%) ▲|TMUS168.60+6.59 (+4.07%) ▲|TSLA381.00+22.78 (+6.36%) ▲|TXN295.80+18.44 (+6.65%) ▲|UBER71.06+2.47 (+3.60%) ▲|UNH396.99+2.84 (+0.72%) ▲|UNP296.64+6.48 (+2.23%) ▲|UPS111.69+3.39 (+3.13%) ▲|USB61.15+1.70 (+2.85%) ▲|V422.36-0.30 (-0.07%) ▼|VZ45.95+0.26 (+0.56%) ▲|WFC85.80+1.86 (+2.22%) ▲|WMT125.63+0.11 (+0.09%) ▲|XOM164.47-1.41 (-0.85%) ▼|
14.7 C
New York
Monday, November 9, 2026

Tag: years

newsFORsourcecompanycontentinformationreleases1IT

Mitrade Trading Platform Partners with Argentine Football Association as Football Fever Sweeps APAC

TAIPEI, July 22, 2025 /PRNewswire/ -- As Argentina's national team jerseys continue to outsell traditional football powerhouses across Southeast Asia and Australia, Mitrade, a global...

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil®...

Neuraxpharm continues international expansion with launch of Neuraxpharm Australia

Avendran Naidu appointed Head of Commercial to lead new affiliate CNS specialist continues growth strategy outside Europe to commercialise CNS treatments, including Nuvigil® (armodafinil), Modavigil®...

EISAI TO PRESENT FOUR-YEAR EFFICACY AND SAFETY DATA ON CONTINUOUS TREATMENT WITH LECANEMAB AT THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025

Latest findings from Eisai's robust Alzheimer's disease (AD) pipeline include results from lecanemab long-term data, an immunoassay for measuring amyloid-β protofibrils in cerebrospinal fluid,...

Biogen to Highlight Scientific Progress Across Alzheimer’s Disease at the Alzheimer’s Association International Conference 2025

CAMBRIDGE, Mass., July 21, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced upcoming scientific presentations at the 2025 Alzheimer’s Association International Conference (AAIC), taking place July 27-31 in Toronto, Canada. Data on LEQEMBI® (lecanemab) will include 48-month results from the Clarity AD open-label extension, real-world evidence, and new insights into a subcutaneous formulation for maintenance dosing. Presentations on tau will explore tau-targeted therapies and biomarkers, including baseline characteristics of participants from CELIA, a Phase 2 trial evaluating the efficacy, safety, and tolerability of BIIB080, an investigational antisense oligonucleotide (ASO) therapy that targets tau.

All-time high – Embraer finished 2Q25 with a US$29.7 billion backlog

Commercial Aviation reported an 8-year backlog record of US$13.1 billion and the division book-to-bill reached 1.8x over the past 12 months,The E175 celebrated an...

CHAMPION IRON ENTERS INTO A DEFINITIVE AGREEMENT WITH NIPPON STEEL AND SOJITZ TO FORM A PARTNERSHIP FOR THE KAMI PROJECT

MONTRÉAL, July 21, 2025 /CNW/ - SYDNEY, July 22, 2025 - Champion Iron Limited (TSX: CIA) (ASX: CIA) (OTCQX: CIAFF) ("Champion" or the "Company") announces...

Safety Shot Announces Pricing of $10.6 Million Registered Direct Offering

SCOTTSDALE, AZ, July 21, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) (“Safety Shot” or the “Company”), a wellness and dietary supplement company, today announced the pricing of a registered direct offering with an institutional investor for the purchase and sale of 28,648,648 shares of its common stock at a purchase price of $0.37 per share.

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

Interleukin-17 Inhibitors Market to Witness Strong Growth During the Forecast Period (2020-2034) Driven by Expanding Indications and Therapeutic Innovation | DelveInsight

The interleukin-17 inhibitors market is expected to remain strong in rheumatology (psoriasis and arthritis), with potential expansion into hidradenitis suppurativa and other dermatologic conditions....

New Found Gold Announces Preliminary Economic Assessment for the Queensway Gold Project

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

Bank of Montreal Announces AT1 Limited Recourse Capital Notes Issue

TORONTO, July 21, 2025 /CNW/ - Bank of Montreal (TSX: BMO) (NYSE: BMO or the "Bank") today announced the pricing of USD 1.0 billion...

New Found Gold Announces Preliminary Economic Assessment for the Queensway Gold Project

Solid low-cost production profile from year one via a phased mine plan:Phase 1: Low Initial capital cost of $155 million, builds average annual gold...

Marine, Mom of Four, Pastry Chef Among Five Winners in Life Time’s First-Ever 60XT Wellness Challenge

Grand prize winners each take home $25,000 in prizes  CHANHASSEN, Minn., July 21, 2025 /PRNewswire/ -- Life Time (NYSE: LTH), the nation's premier healthy lifestyle...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsYears

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers